Login
$IMA
$3.20 -$0.27 (7.78%) Live

$IMA SEC Filings

Filed On Filing
13 Nov 2026 SCHEDULE 13G/A
09 Nov 2026 8-K: Results of Operations and Financial Condition

SAN DIEGO, November 9, 2026 — ImageneBio, Inc. (Nasdaq: IMA) (“Imagene” or the “Company”) today reported financial results for the quarter ended September 30, 2026, and provided a company update.

09 Nov 2026 10-Q
17 Aug 2026 Form 4: Yarema Kristin, Director

Received 254,800 shares as a grant or award · Granted 137,200 Employee Stock Option (right to buy) · Granted 250,000 Employee Stock Option (Right to Buy)

17 Aug 2026 Form 4: Grant-Huerta Yanina, Chief Financial Officer

Received 104,000 shares as a grant or award · Granted 56,000 Employee Stock Option (right to buy)

14 Aug 2026 SCHEDULE 13G/A
11 Aug 2026 EFFECT
11 Aug 2026 EFFECT
06 Aug 2026 EFFECT
05 Aug 2026 S-8
05 Aug 2026 S-3
05 Aug 2026 POS AM
05 Aug 2026 424B3
05 Aug 2026 S-3
05 Aug 2026 10-Q
05 Aug 2026 8-K: Results of Operations and Financial Condition

SAN DIEGO, Aug. 5, 2026 (GLOBE NEWSWIRE) — ImageneBio, Inc. (Nasdaq: IMA) (“Imagene” or the “Company”) today reported financial results for the quarter ended June 30, 2026, and provided a company update.

28 Jul 2026 Form 3: Grant-Huerta Yanina, Chief Financial Officer

No securities owned

28 Jul 2026 Form 4: Yarema Kristin, Director

Received 38,376 shares by exercise or conversion · Acquired 115,129 shares (Other Transaction) · Disposed of 115,129 Restricted Stock Units (Other Transaction)

23 Jul 2026 424B3
23 Jul 2026 8-K: Departure/Election of Directors or Officers; Compensation; Other Events

The ImageneBio, Inc. Severance and Change in Control Plan (the “Plan”) is hereby established by the Compensation Committee of the Board of Directors of ImageneBio, Inc. (the “Company”) effective as of April 27, 2026. The purpose of the P...

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support